RhumbLine Advisers’s ACELYRIN SLRN Stock Holding History

RhumbLine Advisers’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-102,174	Closed	-$252K	–	4252
2025 Q1	$252K	Sell	102,174 -6,069	-6%	-$14.4K	﹤0.01%	2992
2024 Q4	$340K	Buy	108,243 +1,862	+2%	+$9.02K	﹤0.01%	2912
2024 Q3	$524K	Sell	106,381 -2,003	-2%	-$10.3K	﹤0.01%	2666
2024 Q2	$478K	Buy	108,384 +21,859	+25%	+$102K	﹤0.01%	2715
2024 Q1	$584K	Buy	86,525 +41,278	+91%	+$314K	﹤0.01%	2566
2023 Q4	$338K	Buy	45,247 +1,095	+2%	+$9.35K	﹤0.01%	2908
2023 Q3	$449K	Buy	+44,152	New	+$938K	﹤0.01%	2676

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

RhumbLine Advisers's SLRN Position: Q2 2025 in Review

RhumbLine Advisers sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 102,174 shares — an estimated $252K sold.

RhumbLine Advisers first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $584K in Q1 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

RhumbLine Advisers reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
RhumbLine Advisers sold 102,174 ACELYRIN shares in Q2 2025, an estimated $252K.
RhumbLine Advisers first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
RhumbLine Advisers's ACELYRIN position peaked at $584K in Q1 2024.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.